Evidence map›Paper›PMID 41908197›Full record

ArticleHeart rhythm O22026

Feasibility and safety of a novel very-high-power short-duration ablation strategy for superior vena cava isolation.

Toshio Makita, Taishi Kuwahara, Kenta Takahashi, Yurie Arisuda, Takuya Oshio, Kenta Kadono, Yoshimi Oyagi, Yayoi Ito, Ryo Takahashi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toshio MakitaDepartment of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan and.
Taishi KuwaharaDepartment of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan and.
Kenta TakahashiDepartment of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan and.
Yurie ArisudaDepartment of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan and.
Takuya OshioDepartment of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.
Kenta KadonoDepartment of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.
Yoshimi OyagiDepartment of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.
Yayoi ItoDepartment of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.
Ryo TakahashiDepartment of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The optimal radiofrequency (RF) settings for superior vena cava isolation (SVCI), including RF delivery to the lateral superior vena cava segments, which are associated with a risk of phrenic nerve injury (PNI), remain uncertain. Objective: This study aimed to evaluate the clinical feasibility and safety of a novel RF setting of 70 W for 4 seconds for SVCI. Methods: A total of 148 patients undergoing initial SVCI were retrospectively analyzed: 77 received 70 W/4 seconds ablation (70 W group), and 71 received conventional middle-power middle-duration ablation (30-40 W group). Between-group comparisons were performed for procedural outcomes, lesion characteristics, and complications. Results: Procedural success was achieved in all patients in the 70 W group and 96% of the 30-40 W group ( Conclusion: SVCI using 70 W/4 seconds ablation achieved comparable procedural success with significantly reduced ablation time and energy without increasing the risk of PNI even in the lateral superior vena cava segment.

Indexed as

Atrial fibrillationPhrenic nerve injuryRadiofrequency ablationSuperior vena cava isolationVery-high-power short-duration

Identifiers

PMID41908197
PMCPMC13031044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.